Plough,
''we have a product that will probably be low cost to produce compared to any competition''
All nrt have at present is 3 drug candidates which only have pre clinical findings on mice and test tubes with around $40m to pursue their potential success over the next number of years
The market is up 120 points and yet NRT still at 14.5c
DYOR
- Forums
- ASX - By Stock
- Movement
Plough, ''we have a product that will probably be low cost to...
-
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)